Samsung Biologics stock price at 756,000 KRW... up 7.39% from previous day

Samsung Biologics ranked among the top searched stocks on 9 days in the past month.

As of 1:45 PM on the 11th, Samsung Biologics is trading at 756,000 KRW, up 7.39% from the previous day. This represents a 26.63% increase compared to May 18. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have net purchased 25,802 shares of Samsung Biologics, and institutions have net purchased 1,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 209,345 shares, while foreigners and institutions have net bought 99,850 shares and 93,874 shares respectively.

On June 10, Samsung Biologics was a market topic with the headline "New high breaking 700,000 KRW due to large-scale pharmaceutical orders."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.